From Surf Wiki (app.surf) — the open knowledge base
List of antiviral drugs
none
none
Antiviral drugs are different from antibiotics. Flu antiviral drugs are different from antiviral drugs used to treat other infectious diseases such as COVID-19. Antiviral drugs prescribed to treat COVID-19 are not approved or authorized to treat flu.
| Antiviral | Use | Manufacturer | Component | Type | Year approved | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abacavir | HIV | ViiV Healthcare | Nucleoside analogue reverse transcriptase inhibitor (NRTI) | 1998 | ||||||||||||
| Acyclovir (Aciclovir) | Herpes simplex, chickenpox, varicella zoster virus | GSK | guanosine analogue RTI | 1981 | ||||||||||||
| Adefovir | vauthors = Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL | display-authors = 6 | title = Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B | journal = The New England Journal of Medicine | volume = 348 | issue = 9 | pages = 808–16 | date = February 2003 | pmid = 12606735 | doi = 10.1056/NEJMoa020681 | url = https://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=1053&context=intmed_pubs | doi-access = free }} | Gilead Sciences | RTI | 2002 (FDA), 2003 (EU) | |
| Amantadine | Influenza | Influenza A virus M2 proton channel antagonist | 1966 | |||||||||||||
| Ampligen | Avian Influenza | Immunomodulatory double-stranded RNA | 2016 (Argentina) | |||||||||||||
| Amprenavir (Agenerase) | HIV | Protease inhibitor (PI) | 1999 (FDA) | |||||||||||||
| Atazanavir | HIV | PI | 2015 (FDA) | |||||||||||||
| Atripla (Efavirenz/emtricitabine/tenofovir) | HIV | 1998 | ||||||||||||||
| Baloxavir marboxil (Xofluza) | Influenza A/B | Cap snatching endonuclease inhibitor | 2018 | |||||||||||||
| Biktarvy (Bictegravir/emtricitabine/tenofovir alafenamide) | HIV | Gilead Sciences | 2018 | |||||||||||||
| Boceprevir | Hepatitis C genotype 1 | Schering-Plough, then Merck Group | Protease inhibitor | |||||||||||||
| Bulevirtide | Hepatitis D/B | Sodium/bile acid cotransporter inactivator | 2020 (EU) | |||||||||||||
| Cidofovir | AIDS | Viral DNA Polymerase inhibitor | 1996 (FDA) | |||||||||||||
| Cobicistat (Tybost) | HIV | human CYP3A protein inhibitor | ||||||||||||||
| Combivir (Lamivudine/Zidovudine) | HIV | 1997 (FDA) | ||||||||||||||
| Daclatasvir (Daklinza) | Hepatitis C | NS5A inhibitor | ||||||||||||||
| Darunavir | HIV | antiretroviral | HIV PI | |||||||||||||
| Delavirdine | HIV | antiretroviral | NNRTI | |||||||||||||
| Descovy (Emtricitabine/tenofovir alafenamide) | Hepatitis B | |||||||||||||||
| Didanosine | HIV | Adenosine analogue RTI | 1991 (FDA) | |||||||||||||
| Docosanol | Herpes Simplex | Entry inhibitor | 2000 (FDA) | |||||||||||||
| Dolutegravir | HIV | Integrase inhibitor | ||||||||||||||
| Doravirine (Pifeltro) | HIV | Merck & Co | NNRTI | 2018 (FDA) | ||||||||||||
| Edoxudine | Herpes Simplex | Thymidine analogue inhibitor | ||||||||||||||
| Efavirenz | HIV | Mylan | NNRTI | 1998 | ||||||||||||
| Elvitegravir | HIV | Gilead Sciences | Integrase inhibitor | |||||||||||||
| Emtricitabine | HIV | Gilead Sciences | NRTI | 2003 | ||||||||||||
| Enfuvirtide | HIV | Entry inhibitor | 2003 | |||||||||||||
| Ensitrelvir | COVID-19 | Shionogi | [3C-like](3c-like-protease) protease inhibitor | |||||||||||||
| Entecavir | HIV | NRTI | 2005 | |||||||||||||
| Etravirine (Intelence) | HIV | NNRTI | 2008 | |||||||||||||
| Famciclovir | Herpes Zoster | Guanosine analogue | 1994 | |||||||||||||
| Fomivirsen | AIDS | Anti-sense oligonucleotide | Anti-sense | |||||||||||||
| Fosamprenavir | HIV | ViiV Healthcare | Amprenavir pro-drug | 2003 (FDA), 2004 (EMA) | ||||||||||||
| Foscarnet | Herpes | Pyrophosphate analogue DNA polymerase inhibitor | 1991 | |||||||||||||
| Ganciclovir (Cytovene) | 0-9757919-2-3}} | Competitive nucleoside analogue dGTP inhibitor | 1988 | |||||||||||||
| Ibacitabine | Herpes labialis | |||||||||||||||
| Ibalizumab (Trogarzo) | HIV | Entry inhibitor | 2018 | |||||||||||||
| Idoxuridine | Herpes | dU analogue inhibitor | 1962 | |||||||||||||
| Imiquimod | Genital wart, Basal cell carcinoma, Actinic keratosis | Opioid growth factor receptor (OGFr) agonist | 1997 | |||||||||||||
| Inosine pranobex | Herpes Simplex | Thymus hormone immunostimulant | ||||||||||||||
| Indinavir | HIV | PI | 1996 | |||||||||||||
| Lamivudine | HIV | cytidine analogue RTI | ||||||||||||||
| Letermovir (Prevymis) | Cytomegalovirus (CMV) | |||||||||||||||
| Lopinavir | HIV | |||||||||||||||
| Loviride | HIV | |||||||||||||||
| Maraviroc | HIV | entry inhibitor | ||||||||||||||
| Methisazone | Smallpox | |||||||||||||||
| Molnupiravir | COVID-19 | Merck & Co. | viral RNA polymerase inhibitor | |||||||||||||
| Moroxydine | Influenza | |||||||||||||||
| Nelfinavir | HIV | |||||||||||||||
| Nirmatrelvir/ritonavir (Paxlovid) | COVID-19 | Pfizer | [3C-like protease](3c-like-protease) inhibitor (Nirmatrelvir) / inhibition of metabolism of nirmatrelvir (ritonavir) | |||||||||||||
| Nevirapine | HIV | non-nucleoside reverse transcriptase inhibitor | ||||||||||||||
| Nitazoxanide | Broad-spectrum antiviral | thiazolide | ||||||||||||||
| Norvir | HIV | |||||||||||||||
| Oseltamivir (Tamiflu) | Influenza | neuraminidase inhibitor | ||||||||||||||
| Peramivir (Rapivab) | Influenza | |||||||||||||||
| Penciclovir | Herpes | |||||||||||||||
| Pleconaril | Picornavirus | Schering-Plough | ||||||||||||||
| Podophyllotoxin | Genital wart | |||||||||||||||
| Raltegravir | HIV | Integrase inhibitor | ||||||||||||||
| Raphamin | ||||||||||||||||
| Remdesivir | COVID-19 | viral RNA polymerase inhibitor | ||||||||||||||
| Ribavirin | Hepatitis C | nucleoside analogue reverse transcriptase inhibitor | ||||||||||||||
| Rilpivirine (Edurant) | HIV | |||||||||||||||
| Rimantadine | Influenza A | M2 proton channel antagonist | ||||||||||||||
| Ritonavir | HIV | HIV-1 protease inhibitor | ||||||||||||||
| Saquinavir | HIV | |||||||||||||||
| Simeprevir (Olysio) | Hepatitis C | |||||||||||||||
| Sofosbuvir | vauthors = Berden FA, Kievit W, Baak LC, Bakker CM, Beuers U, Boucher CA, Brouwer JT, Burger DM, van Erpecum KJ, van Hoek B, Hoepelman AI, Honkoop P, Kerbert-Dreteler MJ, de Knegt RJ, Koek GH, van Nieuwkerk CM, van Soest H, Tan AC, Vrolijk JM, Drenth JP | title = Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era | journal = The Netherlands Journal of Medicine | volume = 72 | issue = 8 | pages = 388–400 | date = October 2014 | pmid = 25387551 }} | nucleoside analogue reverse transcriptase inhibitor | |||||||
| Stavudine | HIV | |||||||||||||||
| Taribavirin (Viramidine) | Hepatitis Syndromes in which Ribavirin is active | |||||||||||||||
| Telaprevir | Hepatitis C | |||||||||||||||
| Telbivudine (Tyzeka) | Hepatitis B | |||||||||||||||
| Tenofovir alafenamide | Hepatitis B | |||||||||||||||
| Tenofovir disoproxil | Hepatitis B, HIV | |||||||||||||||
| Tipranavir | HIV | |||||||||||||||
| Trifluridine | Eyes related Herpes | |||||||||||||||
| Trizivir | HIV | |||||||||||||||
| Tromantadine | Herpes Simplex | |||||||||||||||
| Truvada | HIV | |||||||||||||||
| Umifenovir (Arbidol) | Influenza | Hemagglutinin inhibitor | ||||||||||||||
| Valaciclovir (Valtrex) | Herpes Simplex/Zoster | |||||||||||||||
| Valganciclovir (Valcyte) | Cytomegalovirus (CMV) | |||||||||||||||
| Vicriviroc | HIV-1 | Schering-Plough | pyrimidine CCR5 entry inhibitor | |||||||||||||
| Vidarabine | Herpes Simplex, Varicella Zoster | |||||||||||||||
| Zalcitabine | HIV | |||||||||||||||
| Zanamivir (Relenza) | Influenza A, Influenza B | |||||||||||||||
| Zidovudine | HIV | Antiretroviral |
References
References
- (15 December 2022). "What You Should Know about Flu Antiviral Drugs".
- "Acyclovir". The American Society of Health-System Pharmacists.
- (February 2003). "Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B". The New England Journal of Medicine.
- (28 October 2019). "Xofluza- baloxavir marboxil tablet, film coated".
- (2008). "Update on viral hepatitis: 2007". Curr. Opin. Gastroenterol..
- (27 August 2020). "Tybost- cobicistat tablet, film coated".
- (10 October 2019). "Pifeltro- doravirine tablet, film coated".
- (9 June 2020). "Intelence- etravirine tablet".
- (19 June 2020). "Cytovene IV- ganciclovir sodium injection, powder, lyophilized, for solution".
- Rossi S, editor. [[Australian Medicines Handbook]] 2006. Adelaide: Australian Medicines Handbook; 2006. {{ISBN. 0-9757919-2-3
- (8 April 2020). "Trogarzo- ibalizumab injection, solution".
- (23 March 2020). "Prevymis- letermovir tablet, film coated PREVYMIS- letermovir injection, solution".
- "Tamiflu- oseltamivir phosphate capsule TAMIFLU- oseltamivir phosphate powder, for suspension".
- (3 August 2020). "Rapivab- peramivir solution".
- "Rebetol, Ribasphere (ribavirin) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Archived from the original on 28 February 2014. Retrieved 23 February 2014.
- (8 June 2020). "Edurant- rilpivirine hydrochloride tablet, film coated".
- (October 2014). "Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era". The Netherlands Journal of Medicine.
- (2006). "Treating HCV with ribavirin analogues and ribavirin-like molecules". The Journal of Antimicrobial Chemotherapy.
- "Tenofovir Disoproxil Fumarate". The American Society of Health-System Pharmacists. Archived from the original on 30 November 2016. Retrieved 29 November 2016.
- (10 December 2019). "Valtrex- valacyclovir hydrochloride tablet, film coated".
- (9 August 2018). "Valcyte- valganciclovir tablet, film coated VALCYTE- valganciclovir hydrochloride powder, for solution".
- (21 June 2018). "Relenza- zanamivir powder".
- "Zidovudine". NCBI.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about List of antiviral drugs — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report